You are here

Article info

Article menu

Download PDFPDF

Research Article
Immunotherapy for Merkel cell carcinoma: a turning point in patient care

Authors

  • Isaac S. Chan Department of OncologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg-Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  • Shailender Bhatia Department of Medicine/Medical OncologyUniversity of Washington and Fred Hutchinson Cancer Research Center Seattle Washington USA PubMed articlesGoogle scholar articles
  • Howard L. Kaufman Department of SurgeryMassachusetts General Hospital Boston MA USA PubMed articlesGoogle scholar articles
  • Evan J. Lipson Department of OncologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg-Kimmel Institute for Cancer Immunotherapy Baltimore MD USA Melanoma and Cancer Immunology ProgramsJohns Hopkins University School of Medicine 1550 Orleans Street, Room 507 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  1. ↵a isaac{at}jhmi.edu
  2. ↵b sbhatia{at}uw.edu
  3. ↵c howard.kaufman{at}rutgers.edu
  4. ↵d 410-502-5977 evanlipson{at}jhmi.edu
View Full Text

Citation

Chan IS, Bhatia S, Kaufman HL, et al
Immunotherapy for Merkel cell carcinoma: a turning point in patient care
Journal for ImmunoTherapy of Cancer 2018;6:23. doi: 10.1186/s40425-018-0335-9

Publication history

  • Received October 24, 2017
  • Accepted March 7, 2018
  • First published March 23, 2018.
Online issue publication 
February 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.